ロード中...
Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
Paclitaxel is a first line chemotherapeutic agent for the patients with metastatic breast cancer. But inherited or acquired resistance to paclitaxel leads to poor response rates in a majority of these patients. To identify mechanisms of paclitaxel resistance, we developed paclitaxel resistant breast...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6434141/ https://ncbi.nlm.nih.gov/pubmed/30911062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-41632-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|